II-VI (NASDAQ:IIVI) PT Lowered to $75.00
II-VI (NASDAQ:IIVI – Get Rating) had its price objective lowered by research analysts at Morgan Stanley from $82.00 to $75.00 in a research report issued on Tuesday, Stock Target Advisor reports. The brokerage currently has an “overweight” rating on the scientific and technical instruments company’s stock. Morgan Stanley’s price target points to a potential upside […]